Quality of life in patients with type 2 diabetes after switching to insulin degludec: results from a cross-sectional survey.
Chioma UzoigweMichael RadinCarol M HamerskyMitch DeKovenCassie HoltSwapna KarkareWilliam H PolonskyPublished in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
Treatment with IDeg after switching from a previous basal insulin was associated with statistically significant improvements in all QoL domains assessed.